We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Determinants of leptin in human breast milk: results of the Ulm SPATZ Health Study.
International Journal of Obesity 2019 June
BACKGROUND: Leptin in human breast milk has been implicated as a potential regulator of early-life metabolic programming. We comprehensively investigated the influence of maternal body mass index (BMI) and non-adiposity associated determinants on breast milk leptin concentration at 6 weeks, 6 months, and 1 year postpartum.
METHODS: The Ulm SPATZ Health Study consists of 1006 newborns and their mothers recruited from the general population in the University Medical Center Ulm, Southern Germany, in 2012/2013. Leptin concentration was measured in skimmed breast milk using commercially available ELISA (R&D System). Generalized estimating equations (GEE) accounting for repeated measures were used to calculate beta coefficients and 95% confidence intervals for association of potential demographic and lifestyle related determinants of hormone concentration with BMI-standardized leptin z-scores.
RESULTS: Leptin concentration was measured in breast milk samples obtained from 694 mothers at approximately 6 weeks (n = 668), 6 months (n = 445), and 1 year (n = 69) postpartum. Differences in crude leptin concentrations between collection times were mostly explained by changes in BMI, breastfeeding frequency, and breast milk fat concentration. Positive associations between BMI and leptin were nonlinear and stronger among lower BMI subjects. Upon standardization, residual leptin concentrations were associated with maternal birth country, parity, age, and smoking history.
CONCLUSIONS: Breast milk leptin concentration is primarily determined by adiposity-related factors. Studies using BMI as a proxy measure for adiposity should account for an observed nonlinear association with leptin, which may be especially important in determining causal associations with health outcomes from this and other adiposity-related hormones in breast milk.
METHODS: The Ulm SPATZ Health Study consists of 1006 newborns and their mothers recruited from the general population in the University Medical Center Ulm, Southern Germany, in 2012/2013. Leptin concentration was measured in skimmed breast milk using commercially available ELISA (R&D System). Generalized estimating equations (GEE) accounting for repeated measures were used to calculate beta coefficients and 95% confidence intervals for association of potential demographic and lifestyle related determinants of hormone concentration with BMI-standardized leptin z-scores.
RESULTS: Leptin concentration was measured in breast milk samples obtained from 694 mothers at approximately 6 weeks (n = 668), 6 months (n = 445), and 1 year (n = 69) postpartum. Differences in crude leptin concentrations between collection times were mostly explained by changes in BMI, breastfeeding frequency, and breast milk fat concentration. Positive associations between BMI and leptin were nonlinear and stronger among lower BMI subjects. Upon standardization, residual leptin concentrations were associated with maternal birth country, parity, age, and smoking history.
CONCLUSIONS: Breast milk leptin concentration is primarily determined by adiposity-related factors. Studies using BMI as a proxy measure for adiposity should account for an observed nonlinear association with leptin, which may be especially important in determining causal associations with health outcomes from this and other adiposity-related hormones in breast milk.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app